Rishi Patel
Private Equity
Rishi is Biovell’s Healthcare Industry Lead in the national Private Equity practice, helping clients capture and build financial and operational value during the hold period for their investments. With 15 years of experience exclusively providing M&A transaction and financial due diligence services to private equity and corporate clients for buy-side, sell-side, and corporate carve-out mandates, Rishi is an expert within the Life Sciences and Healthcare industries specializing in the healthcare provider and services sectors and brings valuable insight to his clients through all phases of the transaction lifecycle. His extensive experience expands the company’s relationships with private equity clients and supports the growth of our transaction advisory capabilities.
Previously, Rishi was a Managing Director within EY’s Health Sciences & Wellness Strategy and Transaction and Deloitte’s Life Sciences & Healthcare M&A Advisory practice focused on transaction diligence. In these roles, he supported clients in executing M&A transactions within various sub-sectors of the healthcare industry including for-profit and not-for-profit hospital systems, post-acute care, retail health, physician practice management and multi-site specialty practices, and behavioral health (substance abuse and mental health). Rishi also has extensive experience with health plans (Medicare Advantage, commercial/HMO, vision and dental plans), benefits and utilization management, and at-risk provider models.
His experience in the life sciences industry includes pharmaceutical manufacturing, medical devices, and contract research and development/ manufacturing organizations.
Rishi received his Bachelor of Science in Business Administration and Masters in Accountancy from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill. He is an active CPA in North Carolina, and member of the AICPA and NCCPA.